Rep. Jared Moskowitz Unloads Cencora, Inc. (NYSE:COR) Shares
by Michael Walen · The Markets DailyRepresentative Jared Moskowitz (Democratic-Florida) recently sold shares of Cencora, Inc. (NYSE:COR). In a filing disclosed on June 19th, the Representative disclosed that they had sold between $1,001 and $15,000 in Cencora stock on May 6th. The trade occurred in the Representative’s “MORGAN STANLEY ACTIVE ASSETS (5)” account.
Representative Jared Moskowitz also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Gilead Sciences (NASDAQ:GILD) on 5/6/2026.
- Purchased $1,001 – $15,000 in shares of General Dynamics (NYSE:GD) on 3/31/2026.
- Sold $1,001 – $15,000 in shares of Cummins (NYSE:CMI) on 3/31/2026.
- Purchased $1,001 – $15,000 in shares of Chubb (NYSE:CB) on 3/31/2026.
- Purchased $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 3/31/2026.
- Purchased $1,001 – $15,000 in shares of American Express (NYSE:AXP) on 3/31/2026.
- Sold $15,001 – $50,000 in shares of Qualcomm (NASDAQ:QCOM) on 3/31/2026.
- Purchased $1,001 – $15,000 in shares of GE Aerospace (NYSE:GE) on 3/31/2026.
- Purchased $1,001 – $15,000 in shares of McDonald’s (NYSE:MCD) on 3/31/2026.
- Purchased $1,001 – $15,000 in shares of Cencora (NYSE:COR) on 3/31/2026.
Cencora Price Performance
Shares of NYSE COR traded down $0.08 during mid-day trading on Friday, reaching $296.43. The company had a trading volume of 1,460,054 shares, compared to its average volume of 1,471,380. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. Cencora, Inc. has a one year low of $244.82 and a one year high of $377.54. The firm has a market cap of $57.67 billion, a price-to-earnings ratio of 22.73, a PEG ratio of 1.65 and a beta of 0.58. The business’s 50-day simple moving average is $277.91 and its 200 day simple moving average is $320.37.
Cencora (NYSE:COR – Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing the consensus estimate of $4.82 by ($0.07). The firm had revenue of $78.36 billion for the quarter, compared to the consensus estimate of $81.09 billion. Cencora had a return on equity of 135.20% and a net margin of 0.78%.The company’s revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period in the prior year, the company earned $4.42 EPS. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, research analysts predict that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.
Cencora announced that its board has initiated a stock repurchase program on Thursday, May 21st that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the company to repurchase up to 3.9% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s board believes its stock is undervalued.
Cencora Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were given a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date was Friday, May 15th. Cencora’s dividend payout ratio is presently 18.40%.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on COR shares. Robert W. Baird reduced their price target on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a research report on Thursday, May 7th. UBS Group upped their target price on Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Wells Fargo & Company reduced their target price on Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a report on Monday, May 11th. Barclays lowered their price target on Cencora from $425.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, June 10th. Finally, Morgan Stanley set a $342.00 price objective on Cencora in a research report on Friday, May 8th. Eleven equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $367.75.
View Our Latest Research Report on Cencora
Insiders Place Their Bets
In other Cencora news, Director Lauren M. Tyler purchased 550 shares of the company’s stock in a transaction on Monday, June 22nd. The shares were purchased at an average cost of $270.23 per share, with a total value of $148,626.50. Following the completion of the purchase, the director owned 4,359 shares in the company, valued at $1,177,932.57. This represents a 14.44% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.38% of the company’s stock.
Hedge Funds Weigh In On Cencora
A number of institutional investors and hedge funds have recently bought and sold shares of COR. T. Rowe Price Investment Management Inc. grew its holdings in shares of Cencora by 160.1% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 6,700,091 shares of the company’s stock worth $2,262,956,000 after purchasing an additional 4,123,795 shares during the last quarter. Norges Bank acquired a new position in Cencora in the fourth quarter valued at $822,506,000. Marshall Wace LLP lifted its stake in shares of Cencora by 518.9% in the 3rd quarter. Marshall Wace LLP now owns 1,995,118 shares of the company’s stock valued at $623,534,000 after purchasing an additional 1,672,762 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Cencora by 528.9% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,475,859 shares of the company’s stock valued at $461,250,000 after purchasing an additional 1,241,186 shares in the last quarter. Finally, Viking Global Investors LP grew its stake in Cencora by 95.0% during the second quarter. Viking Global Investors LP now owns 2,081,732 shares of the company’s stock worth $624,207,000 after purchasing an additional 1,013,913 shares during the period. Institutional investors and hedge funds own 97.52% of the company’s stock.
About Representative Moskowitz
Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida’s 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.
Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida’s 23rd Congressional District. He declared candidacy for the 2026 election.
Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor’s degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz’s career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.
About Cencora
Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.
Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.